Days At A Glance Speakers Session Type Search
Type

    11:00 - 12:45 
    Registration, Lunch and Refreshments
    12:45 - 13:00 
    Welcome from Founding Group
    13:00 - 14:00 
    Appetite and Metabolism
    Mon 09 13:00
    Appetite and Metabolism
    Lecture 1 - Title TBC
    Cambridge, United Kingdom
    Mon 09 13:30
    Appetite and Metabolism
    Lecture 2 - Subcellular architecture of glucagon receptor family signalling
    London, UK
    14:00 - 14:30 
    Oral Presentations 1
    Mon 09 14:00
    OC1
    Oral Presentations 1
    Profiling GIPR signalling mechanisms underlying lipid metabolism rewiring in adipocytes
    London, UK
    Mon 09 14:15
    OC2
    Oral Presentations 1
    Two Succinate GPCR Pathways: Muscle Stem-Cell Sensing and Hypoxia-Induced Epithelial Signalling
    Copenhagen, Denmark
    14:30 - 14:45 
    Coffee Break
    14:45 - 15:45 
    Genetics
    Mon 09 14:45
    Genetics
    Lecture 3 - GLP1 receptor variants and their role in metabolic disease
    France
    Mon 09 15:15
    Genetics
    Lecture 4 - Mapping expression of metabolically relevant GPCRs in the human brain
    Cambridge, UK
    15:45 - 16:15 
    Oral Presentations 2
    Mon 09 15:45
    OC3
    Oral Presentations 2
    Circadian rhythm disruption reduces GLP1 and GIP agonist efficacy in pancreatic beta cells
    Oxford, UK
    Mon 09 16:00
    OC4
    Oral Presentations 2
    SSTR2 Receptor States and Recycling Dynamics Shape the Apparent Affinity of 177Lu-DOTATATE
    Uppsala, Sweden
    16:15 - 16:30 
    Coffee Break
    16:30 - 17:15 
    Keynote
    Mon 09 16:30
    Keynote
    Signalling at the nanoscale: spatiotemporal organisation of the cAMP/PKA pathway
    UK
    17:15 - 19:00 
    Networking Drinks & Posters

    08:00 - 09:00 
    Morning Coffee and refreshments
    09:00 - 10:30 
    Drug Discovery
    Tue 10 09:00
    Drug Discovery
    Lecture 5 - De novo design of miniprotein agonists and antagonists targeting G protein-coupled receptors
    Denmark
    Tue 10 09:30
    Drug Discovery
    Lecture 6 - More than a gut feeling: amylin, the next wave of obesity therapeutics.
    USA
    Tue 10 10:00
    Drug Discovery
    Lecture 7 - Three Names: CRN00808, paltusotine, Palsonify
    USA
    10:30 - 10:45 
    Coffee Break
    10:45 - 11:45 
    Reproductive
    Tue 10 11:15
    Reproductive
    Lecture 9 - Title TBC
    London, UK
    11:45 - 12:15 
    Oral Presentations 3
    Tue 10 11:45
    OC5
    Oral Presentations 3
    A GRK-Biased β₂-Adrenergic Receptor Agonist Induces Coordinated Fat Loss and Muscle Gain via Pathway-Selective Signaling
    Solna, Sweden
    Tue 10 12:00
    OC6
    Oral Presentations 3
    Ligand-PTH1R-βarrestin-complex stability dictates compartmentalized signaling
    Boston, MA, USA
    12:15 - 13:00 
    Lunch & Sponsored Satellite Symposia
    13:00 - 14:00 
    Endocrine
    Tue 10 13:00
    Endocrine
    Lecture 10 - From Orphan to Opportunity: Characterising the physiology and pharmacology of GPR75
    Aberdeen, Scotland
    Tue 10 13:30
    Endocrine
    Lecture 11 - Targeting the PTH-1R
    USA
    14:00 - 14:30 
    Oral Presentations 4
    Tue 10 14:00
    OC7
    Oral Presentations 4
    In vivo role of β-arrestin 2 and GLP-1R and GIPR biased signalling in α-cells
    London, UK
    Tue 10 14:15
    OC8
    Oral Presentations 4
    Spatiotemporally resolved GPCR interactome uncovers unique mediators of receptor agonism.
    Bath, UK
    14:30 - 14:45 
    Coffee Break
    14:45 - 15:15 
    Panel Discussion
    15:15 - 15:30 
    Poster Awards and Closing remarks from the Founding Group
Manuela  Zaccolo
UK
Mon 09 16:30
Keynote
Signalling at the nanoscale: spatiotemporal organisation of the cAMP/PKA pathway
UK
Stephen Betz
USA
Tue 10 10:00
Drug Discovery
Lecture 7 - Three Names: CRN00808, paltusotine, Palsonify
USA
Hamza Bokhari
Solna, Sweden
Tue 10 11:45
OC5
Oral Presentations 3
A GRK-Biased β₂-Adrenergic Receptor Agonist Induces Coordinated Fat Loss and Muscle Gain via Pathway-Selective Signaling
Solna, Sweden
Sina Bondza
Uppsala, Sweden
Mon 09 16:00
OC4
Oral Presentations 2
SSTR2 Receptor States and Recycling Dynamics Shape the Apparent Affinity of 177Lu-DOTATATE
Uppsala, Sweden
Daniel Briere
USA
Tue 10 09:30
Drug Discovery
Lecture 6 - More than a gut feeling: amylin, the next wave of obesity therapeutics.
USA
Charlotte Frazer-Morris
Oxford, UK
Mon 09 15:45
OC3
Oral Presentations 2
Circadian rhythm disruption reduces GLP1 and GIP agonist efficacy in pancreatic beta cells
Oxford, UK
Tom Gardella
USA
Tue 10 13:30
Endocrine
Lecture 11 - Targeting the PTH-1R
USA
Fiona Gribble
Cambridge, United Kingdom
Mon 09 13:00
Appetite and Metabolism
Lecture 1 - Title TBC
Cambridge, United Kingdom
Salim Hanna
Copenhagen, Denmark
Mon 09 14:15
OC2
Oral Presentations 1
Two Succinate GPCR Pathways: Muscle Stem-Cell Sensing and Hypoxia-Induced Epithelial Signalling
Copenhagen, Denmark
Jakob Höppner
Boston, MA, USA
Tue 10 12:00
OC6
Oral Presentations 3
Ligand-PTH1R-βarrestin-complex stability dictates compartmentalized signaling
Boston, MA, USA
Ralf Jockers
France
Mon 09 14:45
Genetics
Lecture 3 - GLP1 receptor variants and their role in metabolic disease
France
Kim Jonas
London, UK
Tue 10 11:15
Reproductive
Lecture 9 - Title TBC
London, UK
Yusman Manchanda
London, UK
Tue 10 14:00
OC7
Oral Presentations 4
In vivo role of β-arrestin 2 and GLP-1R and GIPR biased signalling in α-cells
London, UK
Annabelle Milner
London, UK
Mon 09 14:00
OC1
Oral Presentations 1
Profiling GIPR signalling mechanisms underlying lipid metabolism rewiring in adipocytes
London, UK
Fiona Murray
Aberdeen, Scotland
Tue 10 13:00
Endocrine
Lecture 10 - From Orphan to Opportunity: Characterising the physiology and pharmacology of GPR75
Aberdeen, Scotland
Maria Shchepinova
Bath, UK
Tue 10 14:15
OC8
Oral Presentations 4
Spatiotemporally resolved GPCR interactome uncovers unique mediators of receptor agonism.
Bath, UK
Alejandra Tomas Catala
London, UK
Mon 09 13:30
Appetite and Metabolism
Lecture 2 - Subcellular architecture of glucagon receptor family signalling
London, UK
Jan Voss
Denmark
Tue 10 09:00
Drug Discovery
Lecture 5 - De novo design of miniprotein agonists and antagonists targeting G protein-coupled receptors
Denmark
Professor  Giles Yeo
Cambridge, UK
Mon 09 15:15
Genetics
Lecture 4 - Mapping expression of metabolically relevant GPCRs in the human brain
Cambridge, UK
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 0
No Session Type 21
Mon 09 11:00
Registration, Lunch and Refreshments
Mon 09 12:45
Welcome from Founding Group
Mon 09 13:00
Appetite and Metabolism
Mon 09 13:00
Appetite and Metabolism
Lecture 1 - Title TBC
Cambridge, United Kingdom
Mon 09 13:30
Appetite and Metabolism
Lecture 2 - Subcellular architecture of glucagon receptor family signalling
London, UK
Mon 09 14:00
Oral Presentations 1
Mon 09 14:00
OC1
Oral Presentations 1
Profiling GIPR signalling mechanisms underlying lipid metabolism rewiring in adipocytes
London, UK
Mon 09 14:15
OC2
Oral Presentations 1
Two Succinate GPCR Pathways: Muscle Stem-Cell Sensing and Hypoxia-Induced Epithelial Signalling
Copenhagen, Denmark
Mon 09 14:30
Coffee Break
Mon 09 14:45
Genetics
Mon 09 14:45
Genetics
Lecture 3 - GLP1 receptor variants and their role in metabolic disease
France
Mon 09 15:15
Genetics
Lecture 4 - Mapping expression of metabolically relevant GPCRs in the human brain
Cambridge, UK
Mon 09 15:45
Oral Presentations 2
Mon 09 15:45
OC3
Oral Presentations 2
Circadian rhythm disruption reduces GLP1 and GIP agonist efficacy in pancreatic beta cells
Oxford, UK
Mon 09 16:00
OC4
Oral Presentations 2
SSTR2 Receptor States and Recycling Dynamics Shape the Apparent Affinity of 177Lu-DOTATATE
Uppsala, Sweden
Mon 09 16:15
Coffee Break
Mon 09 16:30
Keynote
Mon 09 16:30
Keynote
Signalling at the nanoscale: spatiotemporal organisation of the cAMP/PKA pathway
UK
Mon 09 17:15
Networking Drinks & Posters
Tue 10 08:00
Morning Coffee and refreshments
Tue 10 09:00
Drug Discovery
Tue 10 09:00
Drug Discovery
Lecture 5 - De novo design of miniprotein agonists and antagonists targeting G protein-coupled receptors
Denmark
Tue 10 09:30
Drug Discovery
Lecture 6 - More than a gut feeling: amylin, the next wave of obesity therapeutics.
USA
Tue 10 10:00
Drug Discovery
Lecture 7 - Three Names: CRN00808, paltusotine, Palsonify
USA
Tue 10 10:30
Coffee Break
Tue 10 10:45
Reproductive
Tue 10 11:15
Reproductive
Lecture 9 - Title TBC
London, UK
Tue 10 11:45
Oral Presentations 3
Tue 10 11:45
OC5
Oral Presentations 3
A GRK-Biased β₂-Adrenergic Receptor Agonist Induces Coordinated Fat Loss and Muscle Gain via Pathway-Selective Signaling
Solna, Sweden
Tue 10 12:00
OC6
Oral Presentations 3
Ligand-PTH1R-βarrestin-complex stability dictates compartmentalized signaling
Boston, MA, USA
Tue 10 12:15
Lunch & Sponsored Satellite Symposia
Tue 10 13:00
Endocrine
Tue 10 13:00
Endocrine
Lecture 10 - From Orphan to Opportunity: Characterising the physiology and pharmacology of GPR75
Aberdeen, Scotland
Tue 10 13:30
Endocrine
Lecture 11 - Targeting the PTH-1R
USA
Tue 10 14:00
Oral Presentations 4
Tue 10 14:00
OC7
Oral Presentations 4
In vivo role of β-arrestin 2 and GLP-1R and GIPR biased signalling in α-cells
London, UK
Tue 10 14:15
OC8
Oral Presentations 4
Spatiotemporally resolved GPCR interactome uncovers unique mediators of receptor agonism.
Bath, UK
Tue 10 14:30
Coffee Break
Tue 10 14:45
Panel Discussion
Tue 10 15:15
Poster Awards and Closing remarks from the Founding Group

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract